Abstract
The polymorphism CYP1A2*1F of the cytochrome 1A2 gene affects the inducibility of this cytochrome, which is involved in the metabolism of many commonly used drugs. We developed a rapid-cycle polymerase chain reaction (PCR) and fluorescent probe melting curve analysis on the LightCycler™ instrument for identification of this mutation. This new method was confirmed by genotyping 101 samples in parallel to restriction enzyme digestion. The 100% concordance of both methods showed the reliability of our high-speed genotyping assay, which is suitable for large epidemiological studies or routine clinical use.
| Originalsprache | Englisch |
|---|---|
| Seiten (von - bis) | 643-646 |
| Seitenumfang | 4 |
| Fachzeitschrift | Pharmacogenomics |
| Jahrgang | 4 |
| Ausgabenummer | 5 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - Sept. 2003 |